Petros Pharmaceuticals, Inc. Capital Expenditures
Petros Pharmaceuticals, Inc. (PTPI) reported Capital Expenditures of $24.59 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-11-13
- Petros Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2024-12-31 was $5.45K.
- Petros Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-12-31 was $0.00.
- Petros Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-09-30 was $204.00.
- Petros Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for the quarter ending 2020-06-30 was $0.00.
- Petros Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $24.59K.
- Petros Pharmaceuticals, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $4.63K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2024-12-31 | $5.45K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $24.59K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | $19.14K 10-Q · filed 2025-11-13 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $204.00 derived: sum of 2 quarters · filed 2022-03-31 | $204.00 derived: sum of 3 quarters · filed 2022-03-31 | $4.63K 10-K · filed 2022-03-31 |
| 2020-09-30 | $204.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $204.00 derived: sum of 2 quarters · filed 2021-11-15 | $4.63K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $4.43K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $4.43K 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |